Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Registers 2.4M Shares for Sale by Stockholders

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today filed documents with the US Securities and Exchange Commission registering 2,370,586 shares of common stock that may be sold from time to time by shareholders.

The shares were issued to the selling stockholders as part of Life Technologies' acquisition of BioTrove in November 2009.They received the shares as part of private placements in December and January.

Life Technologies will not receive any of the proceeds from the sale of the shares that have been registered for this offering.

The firm noted in the prospectus that, under terms of the merger agreement with BioTrove, Life Technologies is required to make earn-out payments to the selling stockholders if cumulative revenue related to the sale of certain assets exceeds a specified amount over the three-year period following the close of the acquisition. If the maximum earn-out is achieved, Life Technologies would issue 1,676,359 shares of common stock.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.